Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.23.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
ASSETS    
Available-for-sale securities, at fair value (amortized cost $9,126,349 and $8,114,627, respectively; allowance for credit losses $5,922 and $6,958, respectively) $ 8,960,820 $ 7,778,734
Mortgage servicing rights, at fair value 3,072,445 2,984,937
Cash and cash equivalents 708,210 683,479
Restricted cash 117,351 443,026
Accrued interest receivable 40,826 36,018
Due from counterparties 317,905 253,374
Derivative assets, at fair value 66,013 26,438
Reverse repurchase agreements 483,916 1,066,935
Other assets 172,805 193,219
Total Assets 13,940,291 13,466,160
Liabilities    
Repurchase agreements 9,084,712 8,603,011
Revolving credit facilities 1,292,831 1,118,831
Term notes payable 398,326 398,011
Convertible senior notes 282,840 282,496
Derivative liabilities, at fair value 1,693 34,048
Due to counterparties 347,337 541,709
Dividends payable 70,746 64,504
Accrued interest payable 74,916 94,034
Commitments and contingencies (see Note 15) 0 0
Other liabilities 141,207 145,991
Total Liabilities 11,694,608 11,282,635
Stockholders' Equity    
Preferred stock, par value $0.01 per share; 100,000,000 shares authorized and 26,092,050 and 26,092,050 shares issued and outstanding, respectively ($652,301 and $652,301 liquidation preference, respectively) 630,999 630,999
Common stock, par value $0.01 per share; 175,000,000 shares authorized and 96,664,318 and 86,428,845 shares issued and outstanding, respectively 967 864
Additional paid-in capital 5,829,676 5,645,998
Accumulated other comprehensive loss (152,780) (278,711)
Cumulative earnings 1,276,563 1,453,371
Cumulative distributions to stockholders (5,339,742) (5,268,996)
Total Stockholders’ Equity 2,245,683 2,183,525
Total Liabilities and Stockholders’ Equity $ 13,940,291 $ 13,466,160